Bellerose, NY, United States of America

Debabrata Banerjee

This inventor holds 7 USPTO granted patents and 2 published patent applications. Top assignees: Rutgers, The State University of New Jersey, Sloan-Kettering Institute for Cancer Research. Active years: 2002-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Debabrata Banerjee. Retrieved from https://idiyas.com/inventor/debabrata-banerjee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 7 

% Patents Active = 28.6

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 22(Granted Patents)


Location History:

  • New York, NY (US) (2003 - 2005)
  • Bellerose, NY (US) (2002 - 2016)

Company Filing History:


Years Active: 2002-2016

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Debabrata Banerjee: Pioneering Advances in Cancer Imaging and Treatment

Introduction

Debabrata Banerjee is a notable inventor based in Bellerose, NY, who has made significant contributions to the fields of medical imaging and oncology. With a remarkable portfolio consisting of seven patents, he stands out for his innovative approaches to cancer treatment and imaging technologies.

Latest Patents

Among his latest patents is the groundbreaking invention titled "System and method for generating three-dimensional images from two-dimensional bioluminescence images and visualizing tumor shapes and locations." This invention provides a system and methods for generating 3D images from 2D bioluminescent images of subjects using any suitable bioluminescent imaging system. The process involves acquiring a series of 2D bioluminescent images, registering them to compensate for differences, and identifying corresponding features. By applying an orthographic projection model, the rays from these features are mapped to produce a detailed 3D image of a tumor.

Another significant patent addresses hormone-refractory prostate cancer, titled "E2F as a target of hormone refractory prostate cancer." This invention provides amino acid sequences that compete with E2F for DNA binding, alongside methods utilizing these sequences for therapeutic interventions in hormone-refractory prostate cancer.

Career Highlights

Throughout his career, Debabrata Banerjee has worked with prestigious institutions such as Rutgers, The State University of New Jersey, and Memorial Sloan Kettering Institute for Cancer Research. His work has significantly advanced the understanding and treatment of cancer, particularly through innovative imaging techniques.

Collaborations

Debabrata has collaborated with esteemed professionals in his field, including Joseph R. Bertino and Dimitris Metaxas. These collaborations have fostered significant advancements and contributed to the success of his numerous inventions.

Conclusion

Debabrata Banerjee is an inspiring inventor whose work continues to have a profound impact on cancer research and treatment. With his innovative patents and collaborations, he exemplifies the critical role that inventors play in advancing medical technology and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…